Carrie Smith Cox

Carrie Smith Cox has an estimated net worth of $49.2 Million. This is based on reported shares across multiple companies, which include TEXAS INSTRUMENTS INC, CARDINAL HEALTH INC, Merck & Co., Inc., Organon & Co., Cartesian Therapeutics, Inc., electroCore, Inc., CELGENE CORP /DE/, ARRAY BIOPHARMA INC, and Solventum Corp.

2011 was Carrie Smith Cox's most active year for acquiring shares with 17 total transactions. Carrie Smith Cox's most active month to acquire stocks was the month of December. 2007 was Carrie Smith Cox's most active year for disposing of shares, totalling 30 transactions. Carrie Smith Cox's most active month to dispose stocks was the month of March. 2007 saw Carrie Smith Cox paying a total of $16,534,728.00 for 1,310,100 shares, this is the most they've acquired in one year. In 2007 Carrie Smith Cox cashed out on 1,800,000 shares for a total of $28,058,550.00, their largest year based on trade value.